Isolated limb perfusion for malignant melanoma
Rosin, R.D.; Westbury, G.
Practitioner 224(1348): 1031-1036
1980
ISSN/ISBN: 0032-6518 PMID: 7220430 Document Number: 155716
Document emailed within 1 workday
Related Documents
Di Filippo, F.; Giacomini, P.; Rossi, C.R.; Santinami, M.; Anzà, M.; Garinei, R.; Perri, P.; Botti, C.; Di Angelo, P.; Sofra, C.; Pasqualoni, R.; Sperduti, I.; Cavaliere, F.; Di Filippo, S.; Corrias, F.; Armenti, A.; Ferraresi, V.; Ginebri, A. 2009: Prognostic factors influencing tumor response, locoregional control and survival, in melanoma patients with multiple limb in-transit metastases treated with TNFalpha-based isolated limb perfusion In Vivo 23(2): 347-352Coit, D.G. 1995: Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion Cancer Journal from Scientific American 1(2): 104-105
Kettelhack, C.; Hohenberger, P.; Schlag, P.M. 1996: Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 113: 127-129
Laurenzi, L.; Natoli, S.; Di Filippo, F.; Calamaro, A.; Centulio, F.; Anzà, M.; Cavaliere, F.; Marcelli, M.E.; Garinei, R.; Arcuri, E. 2004: Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-alpha Journal of Experimental and Clinical Cancer Research: Cr 23(2): 225-231
De Wilt, J.H.; Soma, G.; ten Hagen, T.L.; Kanou, J.; Takagi, K.; Nooijen, P.T.; Seynhaevel, A.L.; Eggermont, A.M. 2000: Synergistic antitumour effect of TNF-SAM2 with melphalan and doxorubicin in isolated limb perfusion in rats Anticancer Research 20(5b): 3491-3496
De Blaauw, J.A.; Rijkenhuizen, A.B.; van Nieuwstadt, R.A.; Grinwis, G.C.; Back, W. 2003: Malignant melanoma of the pelvis as a possible cause of pelvic limb lameness in two gray mares Tijdschrift Voor Diergeneeskunde 128(17): 512-518
Pace, M.; Millanta, L.; Gattai, R.; Matteini, M.; Vaggelli, L.; Macera Mascitelli, E.; Bechi, P. 2007: Key factors for best control of the systemic leakage during hyperthermic isolated limb perfusion (HILP) in ECC. a critical synthesis of our experience Journal of Experimental and Clinical Cancer Research: Cr 26(4): 433-442
Miura, T.; Ishikawa, S. 1970: Malignant melanoma--synopses from the seminar on malignant melanoma by International Group for the Clinical Study of Melanoma Gan no Rinsho. Japan Journal of Cancer Clinics 16(11): 1064-1070
Zwaveling, J.H.; Maring, J.K.; Mulder, A.B.; Bom, V.J.; van Ginkel, R.J.; Schraffordt Koops, H.; Girbes, A.R.; Hoekstra, H.J.; van der Meer, J. 1996: Effects of hyperthermic isolated limb perfusion with recombinant tumor necrosis factor alpha and melphalan on the human fibrinolytic system Cancer Research 56(17): 3948-3953
Yastrebov, I.P.; Surov, D.A.; Belyaev, A.M.; Demko, A.E.; Soloviev, I.A.; Kandyba, D.V.; Gafton, G.I.; Senchik, K.Y.; Kireeva, G.S.; Musii, G.V.; Kirillov, D.A.; Vasilchenko, M.M.; Zenin, A.M.; Falevko, S.Y. 2016: Isolated pelvic perfusion in treatment for malignant tumors Voprosy Onkologii 62(3): 379-389
Shannan, B.; Seifert, M.; Leskov, K.; Boothman, D.; Pföhler, C.; Tilgen, W.; Reichrath, J. 2006: Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro Anticancer Research 26(4a): 2707-2716
Li, T.; Wang, J.; Gao, L.; Yin, Y. 2016: Effect of Simulated in Vivo Physiological Environment Severed Limb Fostering System Applying Remote Ischemic Conditioning Perfusion on Preserving Severed Limb Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 30(1): 91-94
McKay, J.D.; Deacon, A. 2010: Isolated melanoma metastasis to stomach with possible regressed primary lesion: the importance of pursuing solitary melanoma metastases New Zealand Medical Journal 123(1325): 78-79
Kiyohara, Y.; Yoshikawa, S.; Fujiwara, N.; Otsuka, M.; Nakagawa, M.; Yamamoto, A.; Saida, T. 2005: Sentinel node navigation surgery in melanoma and non-melanoma malignant skin tumor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(8): 1191-1194
Monti, M.; Berti, E.; Cavicchini, S.; Paindelli, M.G.; Terragni, L. 1985: Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 120(4): 297-306
Muto, M.; Saito, Y.; Koike, T.; Yamagiwa, Y.; Iijima, K.; Ikeya, S.; Sasaki, T.; Nakayama, H.; Hoshino, E.; Sugai, Y.; Tajiri, H.; Nishihira, T. 1997: Primary malignant melanoma of the esophagus with diffuse pigmentation resembling superficial spreading melanoma American Journal of Gastroenterology 92(10): 1936-1937
Klein-Szanto, A.J.; Silvers, W.K.; Mintz, B. 1994: Ultraviolet radiation-induced malignant skin melanoma in melanoma-susceptible transgenic mice Cancer Research 54(17): 4569-4572
Frydland, M.; Elming, H.; Ahlehoff, O. 2014: Malignant melanoma with metastatic melanoma to the heart Ugeskrift for Laeger 176(25)
Mars, M.; Hadley, G.P. 1992: Pulse oximetry in the assessment of limb perfusion South African Medical Journal 82(6): 486
Ikeda, S.; Ishihara, K.; Taguchi, G. 1985: Phase IIi study of bestatin in patients with malignant skin tumors. (1) Malignant melanoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(1): 77-85